Jones Bryan 4
4 · Aardvark Therapeutics, Inc. · Filed Oct 16, 2025
Insider Transaction Report
Form 4
Jones Bryan
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-15$4.24/sh+1,250$5,300→ 1,250 total - Exercise/Conversion
Stock option (right to buy)
2025-10-15−1,250→ 40,052 totalExercise: $4.24Exp: 2034-07-20→ Common Stock (1,250 underlying)
Footnotes (1)
- [F1]1/48th of the original number of shares subject to the option vested on July 27, 2024, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.